However, there are times when access to tirzepatide may be limited, or insurance coverage could pose challenges
In 2023, the FDA updated the side effects for tirzepatide and semaglutide to emphasize that an ileus, an intestinal blockage, has been reported as a possible side effect
Semaglutide is a long-acting glucagon-like peptide 1 receptor
Individuals taking Wegovy were reported to lose an average of ~35 lbs (or ~15% of their body weight) during the course of the study while individuals in the placebo group lost an average of 6 lbs (or ~2.5% body weight)
The use of Mounjaro has demonstrated an A1C reduction ranging from 2% to 2.3%, while Ozempic has shown an A1C reduction ranging from 1.4% to 2.1%
Do Resistance Training Aim for at least two strength sessions per week to support muscle growth, says Dr